<!DOCTYPE html><html><head><title> Pacifica Code Section 58-17b-S625 </title><link rel="stylesheet" href="../../../assets/style.css"/></head><body>
<b><i>
                      Effective 5/5/2021</i></b>
<br>
<b>58-17b-625.&nbsp;
          </b><b>Administration of a long-acting injectable and naloxone.</b>
<br>
<a id="58-17b-625(1)" name="58-17b-625(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
A pharmacist may, in accordance with this section, administer a drug described in Subsection <a href="#58-17b-625(2)">(2)</a>.</td>
</tr>
</tbody></table>
<a id="58-17b-625(2)" name="58-17b-625(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
Notwithstanding the provisions of Subsection <a href="../../Title58/Chapter17B/58-17b-S102.html?v=C58-17b-S102_2021050520210505#58-17b-102(57)(c)(ii)(B)">58-17b-102(57)(c)(ii)(B)</a>, the division shall make rules in collaboration with the board and, when appropriate, the Physicians Licensing Board created in Section <a href="../../Title58/Chapter67/58-67-S201.html?v=C58-67-S201_1800010118000101">58-67-201</a>, and in accordance with <a href="../../Title63G/Chapter3/63G-3.html?v=C63G-3_1800010118000101">Title 63G, Chapter 3, Utah Administrative Rulemaking Act</a>, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.</td>
</tr>
</tbody></table>
<a id="58-17b-625(3)" name="58-17b-625(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist:
<a id="58-17b-625(3)(a)" name="58-17b-625(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
completes the training described in Subsection <a href="#58-17b-625(2)">(2)</a>;</td>
</tr>
</tbody></table>
<a id="58-17b-625(3)(b)" name="58-17b-625(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrative rule made in accordance with <a href="../../Title63G/Chapter3/63G-3.html?v=C63G-3_1800010118000101">Title 63G, Chapter 3, Utah Administrative Rulemaking Act</a>; and</td>
</tr>
</tbody></table>
<a id="58-17b-625(3)(c)" name="58-17b-625(3)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
is directed by the physician, as that term is defined in Section <a href="../../Title58/Chapter67/58-67-S102.html?v=C58-67-S102_2017050920180701">58-67-102</a> or Section <a href="../../Title58/Chapter68/58-68-S102.html?v=C58-68-S102_2017050920180701">58-68-102</a>, who issues the prescription to administer the drug.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=340&amp;sess=2021GS">340</a>, 2021 General Session<br>
</body></html>